focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: 0.075 (1.03%)
Spread: 0.25 (3.448%)
Open: 7.30
High: 7.375
Low: 7.30
Prev. Close: 7.30
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Feb 2009 16:00

RNS Number : 4596N
Phytopharm PLC
17 February 2009
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Phytopharm plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

AXA S.A>, 25 Avenue Matignon, 75008 Paris and its group of companies

4. Full name of shareholder(s) (if different from 3):

5. Date of transaction (and date on which the threshold is crossed or reached if different):

12/02/2009

6. Date on which issuer notified:

13/02/2009

7. Threshold(s) that is/are crossed or reached:

5%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

0686972

5,561,706

5,561,706

4,289,912

11,000

4,278,912

0.01

4.53

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

4,289,912

4.54

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Name of the Company / Fund Number of shares % of issued share capital

AXA Framlington 4,278,912 4.52563% Indirect

AXA IM UK 11,000 0.01163% Direct

Total Direct 11,000 0.01163%

Total Indirect 4,278,912 4.52563%

TOTAL 4,289,912 4.53727%

Proxy Voting:

10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14 Contact name:

Zoe McGowan

15. Contact telephone number:

01480 437697

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLZDLFFKLBEBBX
Date   Source Headline
29th Aug 201312:01 pmRNSSchedule 1 update - Phytopharm plc
9th Aug 20137:00 amRNSInterim Management Statement
8th Aug 201312:23 pmRNSSchedule 1 update - Phytopharm plc
8th Aug 201311:00 amRNSChange to AIM Admission Timetable
6th Aug 20132:15 pmRNSSchedule 1 - Phytopharm plc
5th Aug 20132:16 pmRNSResult of General Meeting
19th Jul 201311:06 amRNSCancellation of Listing and Admission to AIM
23rd May 20137:00 amRNSInterim Results
21st May 20137:45 amRNSStatement re. Suspension
21st May 20137:30 amRNSTemporary Suspension - Phytopharm Plc
17th May 20139:23 amRNSNotice of Results
27th Mar 201310:15 amRNSAGM Statement
26th Mar 20137:00 amRNSStrategic Review Update
15th Mar 201312:06 pmRNSHolding(s) in Company
18th Feb 20137:00 amRNSResearch Update
13th Feb 20131:59 pmRNSHolding(s) in Company
5th Feb 20137:00 amRNSInterim Management Statement
4th Feb 201311:34 amRNSNotice of AGM
19th Dec 20129:21 amRNSAnnual Financial Report
18th Dec 20127:00 amRNSCogane in ALS Update
17th Dec 201211:00 amRNSBlocklisting Interim Review
22nd Nov 20127:00 amRNSPreliminary Results
9th Nov 20121:32 pmRNSNotice of Results
5th Nov 20121:00 pmRNSBlocklisting Interim Review
17th Oct 20125:27 pmRNSBlocklisting Interim Review
1st Oct 201211:44 amRNSTotal Voting Rights
26th Sep 20127:00 amRNSHolding(s) in Company
31st Aug 20124:40 pmRNSSecond Price Monitoring Extn
31st Aug 20124:35 pmRNSPrice Monitoring Extension
29th Aug 20124:40 pmRNSSecond Price Monitoring Extn
29th Aug 20124:35 pmRNSPrice Monitoring Extension
16th Aug 20127:00 amRNSInterim Management Statement
18th Jun 20129:59 amRNSBlocklisting Interim Review
30th May 20127:00 amRNSHalf Yearly Report
11th May 20127:00 amRNSResearch Update
3rd May 201211:46 amRNSNotice of Results
3rd May 20129:54 amRNSBlocklisting Interim Review
18th Apr 20127:00 amRNSResearch Update
18th Apr 20127:00 amRNSResearch Update
11th Apr 201211:08 amRNSBlock Listing Application
29th Mar 20127:00 amRNSDirectorate Change
28th Mar 20129:35 amRNSResult of AGM
24th Feb 20127:00 amRNSNotice of AGM
16th Feb 20127:00 amRNSInterim Management Statement
14th Feb 20129:34 amRNSHolding(s) in Company
6th Feb 20129:25 amRNSAnnual Information Update
2nd Feb 20127:00 amRNSDirectorate Change
27th Jan 201210:17 amRNSAnnual Financial Report
16th Jan 20127:00 amRNSResearch Update
11th Jan 20123:53 pmRNSBlocklisting Interim Cancellation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.